NCT02684006 2025-07-30
JAVELIN Renal 101
Pfizer
Phase 3 Completed
Clinical Trials
4 trialsNCT06364631 2025-01-16
CARE1
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Recruiting
NCT00920816 2022-05-06
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Pfizer
Phase 3 Completed
NCT00678392 2019-01-09
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Pfizer
Phase 3 Completed